What to know about Foundayo, the newest option if injections aren’t your thing.

Eli Lilly’s newly approved weight-loss pill is expected to generate billions in sales as soon as this year, with analysts betting it will quickly narrow Novo Nordisk’s head start in the oral market.

Lilly's pill has a convenience advantage over Novo's, as it can ​be taken without any ​restrictions and at ⁠any time of day.